135 related articles for article (PubMed ID: 38178201)
1. m
Zhang D; Guo Q; You K; Zhang Y; Zheng Y; Wei T
J Orthop Surg Res; 2024 Jan; 19(1):33. PubMed ID: 38178201
[TBL] [Abstract][Full Text] [Related]
2. circ_0002060 Enhances Doxorubicin Resistance in Osteosarcoma by Regulating the miR-198/ABCB1 Axis.
Ji Y; Liu J; Zhu W; Ji J
Cancer Biother Radiopharm; 2023 Nov; 38(9):585-595. PubMed ID: 33351694
[No Abstract] [Full Text] [Related]
3. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
Ren X; Su C
Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
[TBL] [Abstract][Full Text] [Related]
4. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
5. Has_circ_0010220 regulates the miR-574-3p/IL-6 axis to increase doxorubicin resistance in osteosarcoma.
Gu Y; Wang G; Ran B
Hum Exp Toxicol; 2022; 41():9603271221131307. PubMed ID: 36250452
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m
Ji F; Lu Y; Chen S; Yu Y; Lin X; Zhu Y; Luo X
Cell Death Discov; 2021 Aug; 7(1):215. PubMed ID: 34392306
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p.
Wang X; Cheng Z; Xu J; Feng M; Zhang H; Zhang L; Qian L
Life Sci; 2021 Jan; 265():118788. PubMed ID: 33245966
[TBL] [Abstract][Full Text] [Related]
8. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
[TBL] [Abstract][Full Text] [Related]
9. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
10. N
Liu D; Li Z; Zhang K; Lu D; Zhou D; Meng Y
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4601-4610. PubMed ID: 36171455
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
12. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.
Godel M; Morena D; Ananthanarayanan P; Buondonno I; Ferrero G; Hattinger CM; Di Nicolantonio F; Serra M; Taulli R; Cordero F; Riganti C; Kopecka J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599901
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis.
Zhou W; Liu Y; Wu X
J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476
[TBL] [Abstract][Full Text] [Related]
14. Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.
Roos A; Satterfield L; Zhao S; Fuja D; Shuck R; Hicks MJ; Donehower LA; Yustein JT
Br J Cancer; 2015 Nov; 113(9):1289-97. PubMed ID: 26528706
[TBL] [Abstract][Full Text] [Related]
15. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.
Shen S; Yao T; Xu Y; Zhang D; Fan S; Ma J
Mol Cancer; 2020 Oct; 19(1):151. PubMed ID: 33106166
[TBL] [Abstract][Full Text] [Related]
16. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
Cai T; Zhang C; Zhan T
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
[TBL] [Abstract][Full Text] [Related]
17. High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma.
Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
[TBL] [Abstract][Full Text] [Related]
18. IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells.
He Q; Hao P; He G; Mai H; Liu W; Zhang W; Zhang K; Zhong G; Guo R; Yu C; Li Y; Wong C; Chen Q; Chen Y
J Transl Med; 2022 Aug; 20(1):348. PubMed ID: 35918761
[TBL] [Abstract][Full Text] [Related]
19. CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling.
Fan C; Qu H; Xiong F; Tang Y; Tang T; Zhang L; Mo Y; Li X; Guo C; Zhang S; Gong Z; Li Z; Xiang B; Deng H; Zhou M; Liao Q; Zhou Y; Li X; Li Y; Li G; Wang F; Zeng Z
Cancer Lett; 2021 Jan; 496():41-56. PubMed ID: 32931883
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
